BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24612252)

  • 1. Serial analysis of serum cardiac troponin I changes and correlation with clinical findings in 46 dogs with mitral valve disease.
    Polizopoulou ZS; Koutinas CK; Dasopoulou A; Patsikas M; York M; Roman I; Gandhi M; Patel S; Koutinas AF; O'Brien PJ
    Vet Clin Pathol; 2014 Jun; 43(2):218-25. PubMed ID: 24612252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum cardiac troponin I and acute phase protein concentrations with clinical staging in dogs with degenerative mitral valve disease.
    Polizopoulou ZS; Koutinas CK; Cerón JJ; Tvarijonaviciute A; Martínez-Subiela S; Dasopoulou A; York MJ; Roman IF; Gandhi M; Patel S; O'Brien PJ
    Vet Clin Pathol; 2015 Sep; 44(3):397-404. PubMed ID: 26288324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial measurements of cardiac troponin I in heart failure secondary to canine mitral valve disease.
    Chan IP; Wu SY; Chang CC; Chen WY
    Vet Rec; 2019 Sep; 185(11):343. PubMed ID: 31439824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of mitral valve regurgitation in dogs with degenerative mitral valve disease by use of the proximal isovelocity surface area method.
    Gouni V; Serres FJ; Pouchelon JL; Tissier R; Lefebvre HP; Nicolle AP; Sampedrano CC; Chetboul V
    J Am Vet Med Assoc; 2007 Aug; 231(3):399-406. PubMed ID: 17669041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cardiac troponin I concentration in dogs with precapillary and postcapillary pulmonary hypertension.
    Guglielmini C; Civitella C; Diana A; Di Tommaso M; Cipone M; Luciani A
    J Vet Intern Med; 2010; 24(1):145-52. PubMed ID: 20002552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac troponin-I concentration in dogs with cardiac disease.
    Oyama MA; Sisson DD
    J Vet Intern Med; 2004; 18(6):831-9. PubMed ID: 15638266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease.
    Falk T; Ljungvall I; Zois NE; Höglund K; Olsen LH; Pedersen HD; Häggström J
    J Vet Intern Med; 2013; 27(3):500-6. PubMed ID: 23551840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease.
    Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Souttar K; Elliott J
    J Vet Intern Med; 2012; 26(2):302-11. PubMed ID: 22369312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of atrial natriuretic peptide and cardiac troponin I concentrations for assessment of disease severity in dogs with naturally occurring mitral valve disease.
    Hori Y; Iguchi M; Hirakawa A; Kamiya Z; Yamano S; Ibaragi T; Isayama N; Yamashita Y; Iwasa N; Inaba H; Heishima Y; Yuki M
    J Am Vet Med Assoc; 2020 Feb; 256(3):340-348. PubMed ID: 31961274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac troponin I is associated with severity of myxomatous mitral valve disease, age, and C-reactive protein in dogs.
    Ljungvall I; Höglund K; Tidholm A; Olsen LH; Borgarelli M; Venge P; Häggström J
    J Vet Intern Med; 2010; 24(1):153-9. PubMed ID: 20002554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005).
    Serres FJ; Chetboul V; Tissier R; Carlos Sampedrano C; Gouni V; Nicolle AP; Pouchelon JL
    J Am Vet Med Assoc; 2006 Dec; 229(11):1772-8. PubMed ID: 17144824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical validation and clinical evaluation of a commercially available high-sensitivity immunoassay for the measurement of troponin I in humans for use in dogs.
    Winter RL; Saunders AB; Gordon SG; Miller MW; Sykes KT; Suchodolski JS; Steiner JM
    J Vet Cardiol; 2014 Jun; 16(2):81-9. PubMed ID: 24834862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic variability in NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral valve degeneration.
    Ruaux C; Scollan K; Suchodolski JS; Steiner JM; Sisson DD
    Vet Clin Pathol; 2015 Sep; 44(3):420-30. PubMed ID: 26108974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.
    Ljungvall I; Rajamäki MM; Crosara S; Olsen LH; Kvart C; Borgarelli M; Höglund K; Häggström J
    Am J Vet Res; 2011 Aug; 72(8):1022-8. PubMed ID: 21801058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease.
    Klein S; Nolte I; Granados-Soler JL; Lietz P; Sehn M; Raue JF; Rohn K; Packeiser EM; Bach JP
    BMC Vet Res; 2022 Jul; 18(1):256. PubMed ID: 35780161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly - a randomised, double-blinded trial.
    Iwanuk N; Nolte I; Wall L; Sehn M; Raue J; Pilgram A; Rumstedt K; Bach JP
    BMC Vet Res; 2019 Jul; 15(1):237. PubMed ID: 31288807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J; Gerlach N; Weber K; Klima A; Wess G
    Vet Clin Pathol; 2013 Jun; 42(2):196-206. PubMed ID: 23614733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cardiac troponin I concentrations in dogs with leishmaniasis: correlation with age and clinicopathologic abnormalities.
    Silvestrini P; Piviani M; Alberola J; Rodríguez-Cortés A; Planellas M; Roura X; O'Brien PJ; Pastor J
    Vet Clin Pathol; 2012 Dec; 41(4):568-74. PubMed ID: 22971249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between serum homocysteine concentration and severity of mitral valve disease in dogs.
    Lee CM; Jeong DM; Kang MH; Kim SG; Han JI; Park HM
    Am J Vet Res; 2017 Apr; 78(4):440-446. PubMed ID: 28345991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in dogs with presumed degenerative mitral valve disease attending primary-care veterinary practices in the United Kingdom.
    Mattin MJ; Boswood A; Church DB; Brodbelt DC
    J Vet Intern Med; 2019 Mar; 33(2):432-444. PubMed ID: 30357909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.